North America Neurological Biomarkers Market Insights, Scope And Forecast By 2020-2027

Publisher: The Insight Partners

According to The Insight Partners market research study of ‘North America Neurological Biomarkers Market to 2027 – Regional Analysis and Forecasts by Product, Application, and End User,’ the North America neurological biomarkers market is expected to reach US$ 2,618.68 Mn in 2027 from US$ 7,056.76 Mn in 2019. The market is estimated to grow with a CAGR of 13.4% from 2020-2027.  The report provides trends prevailing in the North America neurological biomarkers market and the factors driving market along with those that act as hindrances.

Based on product, in 2019, the genomic biomarkers segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to increasing awareness among consumers regarding benefits of genetic medicines as well as technological advancements in the field of neurological biomarkers. In addition, the trend shift towards adoption of gene counseling and genetic analysis for diagnostic purposes is also likely to augment the growth of the segment. The genetic biomarkers are significant modalities that directs towards a more personalized approach of predispositions and medical analysis.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013306/

Companies Mentioned

• Thermo Fisher Scientific, Inc
• Bio-Rad Laboratories Inc.
• Banyan Biomarkers
• Abbott
• Quest Diagnostics Incorporated
• Perkin Elmer, Inc

Factors such as growing prevalence of neurological disorders and increasing focus toward research in neurological biomarker are expected to fuel the growth of the market. However, the limitation of neurological biomarkers is a major factor hindering the market growth.

Thermo Fisher Scientific Inc., Abbott, Bio-Rad Laboratories, Inc., Banyan Biomarkers, Inc, Quest Diagnostics Incorporated, and Perkin Elmer, Inc. are some of the leading companies operating in the North America neurological biomarkers market.

NORTH AMERICANEUROLOGICAL BIOMARKERS MARKET SEGMENTATION

By Product

• Proteomics Biomarker
• Genomics Biomarker
• Metabolomics Biomarker
• Imaging Biomarker
• Others

By Application

• Alzheimer’s Disease
• Parkinson's Disease
• Schizophrenia
• Huntington's Disease
• Spinal Muscular Atrophy
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Clinical Diagnostics
• Research Organizations

By Country

• US
• Canada
• Mexico

Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013306/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com